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Purpose: To determine whether epithelial-mesenchymal transition is involved in the development of corneal subepithelial
fibrosis (pannus).
Methods: Frozen samples of pannus tissue removed from human corneas with a diagnosis of total limbal stem cell
deficiency  were  characterized  by  immunostaining  for  both  epithelial  and  mesenchymal  markers.  We  selected
transformation-related protein 63 (p63) and pancytokeratin as epithelial markers and vimentin and α-smooth muscle actin
(α-SMA) as mesenchymal markers. Immunostaining for β-catenin and E-cadherin was performed to determine wingless-
Int (Wnt)-pathway activation. RT–PCR analysis was also performed on epithelial tissue obtained from pannus samples
after dispase digestion.
Results: Immunohistochemistry revealed strong nuclear expression of p63 and weak intercellular expression of E-cadherin
in epithelial basal cells of pannus tissue. Furthermore, translocation of β-catenin from intercellular junctions to the nucleus
and cytoplasm was also observed. Double-positive cells for both p63 and α-SMA were observed in the subepithelial stroma
of pannus tissue, which was supported by RT–PCR and cytospin analysis.
Conclusions: Epithelial-mesenchymal transition may be partially involved in the development of subepithelial corneal
fibrosis due to total limbal stem cell deficiency.
Fibrosis  is  a  common  pathologic  event  observed  in
various organs of the body, including lung and kidney. Recent
studies  have  demonstrated  that  the  cellular  origins  of
fibroblasts during disease are found not only in remnants of
embryonic development, but also in tissue-specific epithelial
cells and circulating cellular pools [1-5]. In particular, there
is the potential for epithelial cells to undergo a change in
phenotype, differentiating into fibroblastic cells in response
to morphogenic pressure from injured tissue in what is known
as epithelial–mesenchymal transition (EMT). Recently, it has
been reported that EMT occurred in a limbal location in rabbit
corneal explant [6], and was also involved in the fibrotic
process in mouse corneal wound healing after alkali burn,
mouse traumatic cataract [7], mouse retinal detachment [8],
and human pterygium [9]. Abnormal subepithelial fibrosis
and epithelial keratinization, in particular, can cause vision-
threatening diseases such as severe ocular surface fibrosis due
to  total  limbal  stem  cell  deficiency  [10,11].
Histopathologically,  corneas  with  total  limbal  stem  cell
deficiency  are  characterized  by  conjunctival  ingrowth
(conjunctivalization),  vascularization  and  chronic
inflammation. Such phenomena may originate from severe
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inflammation  due  to  corneal  burn,  Stevens-Johnson
syndrome, or ocular cicatricial pemphigoid. These diseases
completely  destroy  limbal  epithelial  stem  cells,  their
surrounding environment, or a combination of both.
Generally,  the  mechanism  of  corneal  subepithelial
fibrosis is initiated by corneal stromal fibroblast activation
due to inflammatory cytokines [12,13]. This activation may
then lead to transdifferentiation into α-smooth muscle actin
(α-SMA)-positive  myofibroblasts  [14].  Contraction  of  the
stress  fibers  in  myofibroblasts  subsequently  results  in  the
development  of  fibrosis  [13-15].  We  hypothesized  that
abnormal ocular surface epithelial cells might also contribute
to the fibrotic changes observed in limbal stem cell deficiency.
To  test  this  hypothesis,  we  analyzed  human  corneal
subepithelial  fibrosis  samples  with  limbal  stem  cell
deficiency.
METHODS
Patients: Ten patients with a clinical diagnosis of total limbal
stem cell deficiency confirmed by impression cytology were
included in the study. In some of the patients, an obvious
clinical diagnosis of total limbal stem cell deficiency obviated
the  need  for  cytological  confirmation  (Figure  1A).  The
etiologies  included  chemical  burn  (n=3),  Stevens-Johnson
syndrome (n=4), ocular cicatricial pemphigoid (n=1), pseudo-
ocular cicatricial pemphigoid (n=1), and aniridia (n=1; Table
1). None of the patients had undergone surgical procedures
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2727for  ophthalmological  disorders  before  receiving  ocular
surface  reconstruction  at  our  facility.  With  prior  written
informed consent, clinical samples of pannus were obtained
from these patients intraoperatively.
The pannus specimens (Figure 2B) were immediately
embedded and frozen for sectioning and maintained at −80 °C
for  immunostaining.  After  dispase  digestion,  Reverse
Transcription-Polymerase  Chain  Reaction  (RT–PCR)  was
Figure 1. Histopathology of pannus. Clinical appearance of patient
(case 7) showed thin pannus covering whole cornea (A). Removed
pannus in case 7 (B). Representative pannus photo of hematoxylin-
eosin staining (C) showing irregular epithelial basal layer and hyper-
epithelialization associated with increased subepithelial fibroblasts.
used  to  analyze  two  samples  of  obtained  epithelia  from
pannus. For cytospin, separately prepared pannus samples
were digested with dispaseII for 1 h at 37 °C and Trypsin-
EDTA at 37 °C for 5 min. Cytospin-slides were stored at
−80 °C for immunostaining.
Normal human corneas were obtained from Northwest
Lions  Eyebank  (Seattle,  WA)  as  a  control.  All  research
protocols were approved by the appropriate ethics committees
of Tokyo Dental College and all procedures performed in
accordance with the tenets of the Declaration of Helsinki.
Histology and immunofluorescent staining: A normal section
comprising  cornea  and  limbus  was  used  as  the  control.
Figure 2. Immunostaining of pannus tissue against pancytokeratin
(CK22).  Epithelium  of  pannus  in  all  cases  stained  positive  for
pancytokeratin (red), particularly in superior hyperepithelial layers.
However,  basal  cells  showed  weak  staining  (A  and  B).  C:
pancytokeratin staining in normal cornea as a control. The scale bar
indicates 50 μm.
TABLE 1. DEMOGRAPHIC DATA.
Case Age Sex Original disease Examination
1 34 M Chemical burn IHC
2 33 F Chemical burn IHC
3 10 M AB IHC
4 80 F SJS IHC
5 42 F SJS IHC
6 47 M SJS IHC
7 69 M OCP IHC
8 82 F pOCP IHC
9 62 F aniridia RT–PCR
10 57 M SJS RT–PCR
        AB=alkali  burn,  SJS=Stevens-Johnson  syndrome,  OCP=ocular  cicatricial  pemphigoid,  OCP=pseudo-OCP,
        IHC=immunohistochemistry.
TABLE 2. PCR PRIMER SEQUENCES.
  Sequence    
Name Forward Reverse Product size
(bp)
Melting
temperature
α-SMA ACTGGGACGACATGGAAAAG CATCTCCAGAGTCCAGCACG 241 60
matrix metalloproteinase (MMP)-2 AGATCTTCTTCTTCAAGGACCGGTT GGCTGGTCAGTGGCTTGGGGTA 225 65
MMP9 GCGGAGATTGGGAACCAGCTGTA GACGCGCCTGTGTACACCCACA 208 64
E-cadherin TCGACACCCGATTCAAAGTGG TTCCAGAAACGGAGGCCTGAT 194 58
beta-Catenin GCTGATTTGATGGAGTTGGA GCTACTTGTTCTTGAGTGAA 226 54
Snail-1 TATGCTGCCTTCCCAGGCTTG ATGTGCATCTTGAGGGCACCC 145 61
GAPDH ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA 452 58
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2728Multiple 5-μm-thick frozen sections were prepared on gelatin-
coated slides, fixed with 2% paraformaldehyde for 5 min and
reacted with anti–p63 (Santa Cruz Biotechnology, Inc. Santa
Cruz,CA), anti-β-catenin (Santa Cruz, CA), anti-E-cadherin
(Santa Cruz CA), anti-pan cytokeratin (Abcam, Cambridge,
UK),  anti-α-SMA  (Abcam),  anti-vimentin  (Neomarkers,
Fremont,  CA)  and  anti-collagen  4  (Southern  Biotec,
Birmingham, AL) antibodies. Sections were then treated with
Cy3-  or  FITC-,  Alexa  Fluor  488-conjugated  secondary
antibodies  (Chemicon  International,  Temecula,  CA).  Cell
nuclei  were  counterstained  with  DAPI  (1  µg/ml;
Dojindo  Laboratories,  Tokyo,  Japan).  For  histological
examination,  hematoxylin  eosin  staining  was  performed
according to the standard procedure. Double immunostaining
for p63 and α-SMA was performed in the cytospin-slides.
Reverse  transcription–polymerase  chain  reaction:  After
digestion by dispase, total RNA was extracted from epithelial
cells  using  a  commercial  kit  (RNeasy;  Qiagen,  Hilden,
Germany), followed by cDNA synthesis (RevaTra Ace-- kit;
Toyobo  Co.  Ltd.,  Osaka,  Japan).  PCR  was
performed  (GeneAmp  9700;  Applied  Biosystems,  Foster
City,  CA)  with  the  Advantage  2  PCR  Enzyme  System
(Clontech, Takara Bio Inc., Shiga, Japan) as follows: 95 °C
for 5 min, 2 cycles of 95 °C for 90 s, 57 °C for 30 s, and 72 °C
for 30 s, and 28 cycles of 95 °C for 30 s, 57 °C for 30 s, and
72 °C for 30 s. Sequences for primers are shown in Table 2.
PCR products were analyzed by gel electrophoresis.
Figure  3.  Immnostaining  of  pannus  tissue  against  vimentin  and
collagen IV. Compared to control (C, normal cornea), collagen IV
expression (red) was irregular in pannus, and was also found in vessel
walls (A and B). Vimentin(+) (green) stromal cells were uniformly
observed in normal central cornea, but supra- and sub-epithelial
activated vimentin(+) cells were observed in pannus. Cells double-
positive for vimentin and p63 were observed (D, indicated by arrow).
The scale bar indicates 50 μm.
RESULTS
Histopathology and immunohistochemistry of pannus: We
investigated whether EMT had occurred in pannus tissue by
immunohistochemical  analysis.  For  phenotypic  analysis,
vimentin and α-SMA were selected as mesenchymal markers
and  pan-cytokeratin  (K)  and  p63  as  epithelial  markers.
Nuclear  and  cytoplasmic  translocation  of  β-catenin
expression was also determined as a marker for EMT. Full-
thickness  epithelium  in  the  pannus  and  normal  corneal
epithelium  tested  positive  for  pancytokeratin  in  all  cases,
although the strength of staining differed. Basal cells showed
very weak staining for pancytokeratin (Figure 2). Compared
to  the  control,  the  basal  membrane  was  irregular  and
subepithelial vascularization was noted in pannus (Figure 3).
In normal cornea, collagen type 4 showed a regular pattern of
expression in the basement membrane layer, as indicated by
the red line in Figure 3C. However, in pannus tissue and the
vessel walls, expression of collagen type 4 showed an increase
or was irregular. Vimentin(+) stromal cells were uniformly
observed in normal central cornea, whereas supra- and sub-
epithelial-activated  vimentin(+)  cells  were  observed  in
pannus tissue (Figure 3). Furthermore, double-positive cells
for  both  epithelial  marker  nuclear  p63  and  mesenchymal
marker vimentin were observed in pannus tissue (Figure 3D).
As shown in Figure 4, intact corneal epithelium was positive
for membrane E-cadherin and β-catenin. Epithelial basal cells
in pannus tissue showed weak expression of E-cadherin and
translocation of β-catenin from intercellular junctions to the
cytoplasm (Figure 4), indicating at least partial dissolution of
cell-cell junctions. No expression of α- SMA was observed in
Figure  4.  Immunohistochemistry  of  E-cadherin  and  β-catenin.
Epithelial basal cells in pannus showed weak staining for E-cadherin
(green)  and  translocation  of  β-catenin  (red)  from  intercellular
junctions  to  cytoplasm.  A:  Pannus  with  double-staining  for  E-
cadherin  and  β-catenin.  B:  Normal  cornea.  C:  βcatenin,  D:  E-
cadherin, E: E-cadherin and DAPI, in pannus epithelium was shown.
A was a combination of C, D, and E. The scale bar indicates 50 μm.
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2729intact  normal  cornea  by  immunohistochemistry  (data  not
shown).  Double-positive  cells  for  both  epithelial  marker
nuclear p63 and mesenchymal marker cytoplasmic α-SMA
were  observed  in  subepithelial  locations  in  pannus  tissue
(Figure  5).  Furthermore,  cytospin  of  pannus  epithelium
revealed cells with positive immunostaining for both nuclear
p63 and cytopkasmic α-SMA, which supported the findings
in the tissue sections (Figure 6).
RT–PCR results: Weak expression of α-SMA and MMP-2 and
no expression of MMP-9 were observed in normal limbal
epithelial  cells.  On  the  other  hand,  motility-associated
proteins α-SMA, MMP-2, and MMP-9 were all expressed in
samples  of  pannus  tissue  (representative  data,  Figure  7),
which  supported  the  immunostaining  data.  Weak  Snail-1
expression was also observed in pannus tissue. E-cadherin and
β-catenin were expressed in both normal limbal epithelial
cells and pannus.
DISCUSSION
The results of this study indicate that EMT may be involved
in the development of corneal pannus due to limbal stem cell
deficiency. Kawakita et al. [6] previously reported that rabbit
corneal limbal epithelial cells underwent EMT and invaded
underlying stroma after exposure to air in a rabbit limbal
explant model. This suggests that putative corneal epithelial
progenitor cells in the basal limbal layer can differentiate into
mesenchymal cells, which would agree with the histologic
findings on fibrosis in this study. Therefore, it is reasonable
to hypothesize that EMT in altered limbal epithelial cells is
involved in the pathogenesis of pannus.
Fibrotic diseases of the ocular surface, including corneal
and  conjunctival  scar,  have  been  recognized  as  having  a
mechanism quite similar to that of fibrotic disorders in other
tissues of the human body. Inflammation is thought to trigger
Figure 5. Immunostaining of pannus tissue against p63 and α-SMA.
Nuclear p63 (red) and cytoplasmic α- SMA (green) double-positive
cells were observed in subepithelial location in pannus tissue (A and
B). B was syntheses photo of p63 (C), α- SMA (D), and DAPI (E).
Scale bar indicates 50 μm.
and  facilitate  the  progression  of  fibrosis.  Subsequently,
epithelial cells are stimulated and injured without appropriate
repair, resulting in activation of underlying fibroblasts. These
fibroblasts derive from bone marrow, but may also arise as a
result of EMT in cells at injury sites [16]. This process of
fibrotic tissue transformation is characterized by an increase
in abnormal extracellular matrix, including collagen fibers.
Such an excess accumulation of extracellular matrix and the
appearance  of  α-SMA-positive  myofibroblasts  and
inflammatory cells were observed in all the pannus samples
in this study. Several studies have reported α- SMA as a
marker for EMT during fibrosis [17-19]. No expression of α-
SMA was observed in intact cornea. Although it is not clear
whether they were vessel cell-derived or not in this study,
double-positive cells for both nuclear p63 and cytoplasmic α-
SMA  were  observed  in  subepithelial  locations  in  pannus
tissue (Figure 5). Moreover, cytospin revealed both p63 and
α-SMA  in  pannus  tissue-derived  cells  (Figure  6).  Taken
together, these results suggest that EMT occurs in pannus
tissue.
The process of EMT requires alterations in morphology,
cellular  architecture,  adhesion  and  migration  capacity.
Commonly  used  molecular  markers  for  EMT  include
increased  expression  of  N-cadherin  and  vimentin,  nuclear
localization  of  β-catenin  and  increased  production  of
transcription factors such as Snail1 (Snail) and Snail2 (Slug),
which inhibit E-cadherin production [1-5,20-24]. Phenotypic
markers for EMT include an increased capacity for migration
and 3-dimensional invasion, as well as resistance to anoikis/
apoptosis  [1-5].  MMP-2  and  −9  have  been  shown  to  be
important in both normal corneal wound healing and EMT-
like changes in tumor formation [25,26]. In this study, EMT
was evidenced by morphological alteration and expression of
the fibroblast phenotypic marker vimentin, concomitant with
downregulation of epithelial phenotype marker E-cadherin.
Expression of Snail 1,MMP-2, and MMP-9 RNA was also
upregulated (Figure 7). Epithelial basal cells in pannus tissue
showed weak expression of E-cadherin and translocation of
Figure 6. Immunostaining of cytospin of pannus tissue. Double-
immunostaining for p63 (red) and α-SMA (green) was observed in
individual cells (indicated by arrows) in cytospin of pannus (A, with
DAPI staining; B, without DAPI staining).  Scale bar indicates 50
μm.
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2730β-catenin from intercellular junctions to the cytoplasm in the
immunohistological examination. This agreed with the results
of earlier studies showing activation of the Wnt signaling
pathway, a major signal transduction pathway of EMT [2,9,
27,28]. However, RT–PCR levels of E-cadherin and β-catenin
showed no change between pannus epithelial cells and control
limbus  cells  in  this  study,  which  may  have  been  due  to
hyperkeratinization.
In this context, MT1-MMP plays an important role by
activating other MMPs such as proMMP-2 at the cell surface
[29,30].  Activation  of  proMMP-2  by  MT1-MMP  is
considered to be a pivotal step in tumor cell invasion, as
Figure  7.  RT-PCR  of  pannus  epithelium.  α-SMA,  MMP-2,  and
MMP-9 were all expressed in pannus epithelium, but not in limbal
epithelium.    Weak  Snail-1  expression  was  observed  in  pannus
epithelium. E-cadherin and β-catenin were expressed in both  limbal
epithelial cells and pannus.
activated MMP-2 degrades collagen type IV and laminin, the
major components of basement membranes [31,32]. Increase
in corneal epithelial MMP-2 expression in pannus tissue may
be a step in the EMT process.
In this study, we demonstrated that the Wnt/β-catenin
pathway  was  activated  in  basal  epithelial  cells  in  human
pannus samples. Proteases such as MMP2 might play a major
role in the migration/invasion process of EMT. The number
of α-SMA-positive, activated (myo) fibroblasts increased in
pannus  fibrosis.  However,  their  origin  remains  to  be
elucidated in further study.
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